Research by Phable, a chronic disease management app, unveiled some insights from their recent clinical studies related to Hypertension and Type 2 Diabetes. The studies were presented at the BPCON Conference 2022 – Annual Meeting of Indian Society of Hypertension, Lucknow and at the RSSDI Conference 2022 – Annual Meeting of Research Society of the Study of Diabetes in India, Chennai.
According to the study, digital therapeutics (DTx) intervention, applied through Phable’s proprietary algorithm and smartphone devices, helped chronic disease patients regain control of their health.
Chronic diseases such as Type 2 Diabetes and Hypertension are called lifestyle diseases as their risk factors are linked to one’s way of living. The management of these conditions requires regular self-monitoring and behavior change, which seem like the easiest things to do but are difficult to stick to. Health-related behavior change needs consistency and constant nudging to become an implementable reality.
Technology-driven behavior changes powered by its algorithm and applied through a smartphone, can be the constant companion that chronic disease patients need. Using smartphones, wearables, and monitoring devices, patients can self-monitor their health parameters and report them to the app. The proprietary algorithm takes in the health signals and suggests suitable actions to help drive behaviour change and treatment adherence in patients. Chronic disease patients can take control of their health with Phable, which is supported by the expertise of 17,000 doctors and the experience of helping 4.5 million Indians on their health journey. The study on the role of Digital Therapeutics in the management of Type 2 Diabetes was conducted over a period of 12 weeks in Type 2 Diabetes patients. The DTx intervention included a specifically designed interactive and algorithmic management of diet, physical movement, health education, and self-monitoring via the Phable App.
The study further found that patients with Type 2 Diabetes benefited significantly from the Diabetes Management program, as seen by a reduction of their HbA1c values (an average of blood glucose levels in the past 3 months) at the end of the 12-week period. Particularly, patients with higher severity of Diabetes saw a significantly greater improvement in blood sugar control.
The results further showed; compared to conventional healthcare models, Phable’s DTx-enabled intervention has proved to be more effective in improving blood sugar control through behaviour change and self-management of Diabetes in patients.
Meanwhile, the study on blood pressure control was conducted over 12 weeks on patients with uncontrolled hypertension (BP =140/90 mmHg) under stable treatment. The interventions under DTx included proprietary algorithmic management of hypertension through – dietary modification, stress management, physical activity, patient education, and self-monitoring.
The results clearly establish the effectiveness of Phable’s DTx intervention in improving the blood pressure values of patients through behaviour modification and self-management of hypertension. chronic diseases. A sustained DTx intervention.
